Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

GW Pharma Attains 52-Week High on Positive Epidiolex Data
GW Pharma Attains 52-Week High on Positive Epidiolex Data
GW Pharmaceuticals plc’s shares are riding high after the company reported third consecutive positive phase III data on its lead cannabinoid pipeline candidate, Epidiolex, so far this year.
U.N. Calls Antibiotics in Food a Health Crisis on Par With AIDS
U.N. Calls Antibiotics in Food a Health Crisis on Par With AIDS
The CDC says 23,000 Americans die a year from drug-resistant bacteria.
Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint
Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint
BOULDER, CO, USA I September 26, 2016 I Array BioPharma (ARRY) and Pierre Fabre today jointly announced top-line results from Part 1 of the Phase 3 COLUMBUS (Combined LGX818 Used with MEK1...
Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
PALO ALTO, CA, USA I September 26, 2016 I Orbus Therapeutics Inc.
Mylan faces scrutiny over EpiPen profit data shown to Congress
Mylan faces scrutiny over EpiPen profit data shown to Congress
Mylan NV (MYL.
UK okays Alexion drug costing up to $2 million but wants price cut
UK okays Alexion drug costing up to $2 million but wants price cut
A new drug to treat a rare inherited bone disorder that was developed by Alexion Pharmaceuticals and could cost up to 1.
US FDA approves labeling update of Rexulti® (brexpiprazole) for maintenance treatment of schizophrenia
US FDA approves labeling update of Rexulti® (brexpiprazole) for maintenance treatment of schizophrenia
VALBY, Denmark and PRINCETON, NJ, USA I September 23, 2016 I H.
AbbVie Presents Data on Eight-Week Treatment of VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) in Patients with Genotype 1b Chronic Hepatitis C
AbbVie Presents Data on Eight-Week Treatment of VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) in Patients with Genotype 1b Chronic Hepatitis C
NORTH CHICAGO, IL, USA I September 23, 2016 I AbbVie (NYSE.
With U.S. drone rules set, firms race for flight data
With U.S. drone rules set, firms race for flight data
United Parcel Service Inc's launch this week of drone test flights simulating emergency medical-supply deliveries highlights a race for data to prove such deliveries can be performed safely.
Lundbeck says Alzheimer's drug fails in late-stage study
Lundbeck says Alzheimer's drug fails in late-stage study
Danish drugmaker H Lundbeck A/S's highly anticipated experimental Alzheimer's drug failed in a late-stage study, underscoring the challenges faced by drugmakers to tackle the debilitating memo...
Moderna lays out ambitious $110M facility for clinical supplies
Moderna lays out ambitious $110M facility for clinical supplies
Moderna Therapeutics, the much-ballyhooed Cambridge-based biotech developing a cutting-edge mRNA treatment platform, says it will build a $110 million manufacturing plant to handle the clinical trial ...
Turing Pharmaceuticals AG Announces Development of New Drug Candidates for Toxoplasmosis
Turing Pharmaceuticals AG Announces Development of New Drug Candidates for Toxoplasmosis
ZUG, Switzerland I September 22, 2016 I Turing Pharmaceuticals AG today announced that it has advanced several experimental compounds into pre-clinical development.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand